These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 9974186)

  • 1. Effect of clodronate on gene expression in the peripheral blood of horses.
    Wilcox CV; Knych HK; Katzman SA; Arthur RM; Rodriguez V; Finno CJ
    J Vet Pharmacol Ther; 2024 May; 47(3):187-192. PubMed ID: 38197553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically relevant doses of tiludronate do not affect bone remodelling in pasture-exercised horses.
    Tippen SP; Metzger CE; Sacks SA; Allen MR; Mitchell CF; McNulty MA
    Equine Vet J; 2024 Jun; ():. PubMed ID: 38924597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis.
    Hosny KM; Rizg WY
    PLoS One; 2018; 13(6):e0197540. PubMed ID: 29856752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of bisphosphonates in the aorta and some other tissues of healthy and atherosclerotic rabbits.
    Ylitalo R; Mönkkönen J; Urtti A; Ylitalo P
    J Lab Clin Med; 1996 Feb; 127(2):200-6. PubMed ID: 8636649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the distribution of three bisphosphonates in mice.
    Mönkkönen J; Koponen HM; Ylitalo P
    Pharmacol Toxicol; 1990 Apr; 66(4):294-8. PubMed ID: 2142526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of bisphosphonates into insoluble material in human blood in vitro.
    Kautiainen S; Luurila S; Ylitalo P; Ylitalo R
    Methods Find Exp Clin Pharmacol; 1998 May; 20(4):289-95. PubMed ID: 9658377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro.
    Ylitalo R; Kalliovalkama J; Wu X; Kankaanranta H; Salenius JP; Sisto T; Lähteenmäki T; Ylitalo P; Pörsti I
    Pharmacol Toxicol; 1998 Sep; 83(3):125-31. PubMed ID: 9783331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of bisphosphonates in rabbits.
    Luurila S; Kautiainen S; Ylitalo P; Ylitalo R
    Pharmacol Toxicol; 1999 Jan; 84(1):24-8. PubMed ID: 9974186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates: preclinical aspects and use in osteoporosis.
    Fleisch HA
    Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate therapy.
    Licata AA
    Am J Med Sci; 1997 Jan; 313(1):17-22. PubMed ID: 9001162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates in the treatment of osteoporosis.
    Bell NH; Johnson RH
    Endocrine; 1997 Apr; 6(2):203-6. PubMed ID: 9225137
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.